LEMAITRE VASCULAR, INC. (LMAT)

Every figure this model derived for LMAT, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 9,154,000 PaymentsToAcquireProductiveAssets 2026-06-30
cash 376,240,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 488,297,000 AssetsCurrent 2026-06-30
current liabilities 29,935,000 LiabilitiesCurrent 2026-06-30
equity 420,342,000 StockholdersEquity 2026-06-30
interest expense 5,197,000 InterestExpense 2026-06-30
ocf 82,979,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 262,432,000 RevenueFromContractWithCustomerIncludingAssessedTax 2026-06-30
sbc 7,863,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up LMAT on one particular measure came for.

RatioValue
cash operating margin36.46
current ratio16.31
current ratio reported16.31
dilution pct0.66
ebit cagr35.36
ebit yoy41.17
fcf margin28.13
growth cv0.38
interest cover14.88
operating margin29.46
owner earnings margin25.13
revenue growth11.85
revenue growth per share11.11
roic28.65
rule of 4041.31
sbc pct revenue3.0

What to be careful about

What this model itself distrusts about LMAT's figures. Written by the derivation as it ran, not added afterwards.